Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Integra Lifesciences Holdings (IART) Other Gross PP&E Adjustments (2016 - 2025)

Integra Lifesciences Holdings (IART) has disclosed Other Gross PP&E Adjustments for 16 consecutive years, with $740.4 million as the latest value for Q4 2025.

  • Quarterly Other Gross PP&E Adjustments rose 13.86% to $740.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $740.4 million through Dec 2025, up 13.86% year-over-year, with the annual reading at $740.4 million for FY2025, 13.86% up from the prior year.
  • Other Gross PP&E Adjustments hit $740.4 million in Q4 2025 for Integra Lifesciences Holdings, up from -$165.1 million in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $740.4 million in Q4 2025 to a low of -$218.1 million in Q1 2025.
  • Historically, Other Gross PP&E Adjustments has averaged $16.6 million across 5 years, with a median of -$166.2 million in 2022.
  • Biggest five-year swings in Other Gross PP&E Adjustments: crashed 55.26% in 2022 and later grew 19.9% in 2024.
  • Year by year, Other Gross PP&E Adjustments stood at $528.1 million in 2021, then decreased by 8.62% to $482.6 million in 2022, then grew by 12.39% to $542.3 million in 2023, then rose by 19.9% to $650.3 million in 2024, then rose by 13.86% to $740.4 million in 2025.
  • Business Quant data shows Other Gross PP&E Adjustments for IART at $740.4 million in Q4 2025, -$165.1 million in Q3 2025, and -$190.3 million in Q2 2025.